Gene: ERBB2 ×
Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Therapeutic disease CTD_human Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. 19436038 2009
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Biomarker disease CTD_human Mouse breast cancer model-dependent changes in metabolic syndrome-associated phenotypes caused by maternal dioxin exposure and dietary fat. 18840765 2009
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Therapeutic disease CTD_human Mouse breast cancer model-dependent changes in metabolic syndrome-associated phenotypes caused by maternal dioxin exposure and dietary fat. 18840765 2009
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Biomarker disease CTD_human Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance. 19075277 2009
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Therapeutic disease CTD_human Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins. 19801490 2009
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Therapeutic disease CTD_human Type 1 receptor tyrosine kinase profiles identify patients with enhanced benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial. 18768436 2008
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Therapeutic disease CTD_human [Efficacy and toxicity of trastuzumab combined vinorelbine in 21 patients with HER2 overexpressing metastatic breast cancer]. 18819904 2008
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Biomarker disease CTD_human Type 1 receptor tyrosine kinase profiles identify patients with enhanced benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial. 18768436 2008
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Biomarker disease CTD_human [Efficacy and toxicity of trastuzumab combined vinorelbine in 21 patients with HER2 overexpressing metastatic breast cancer]. 18819904 2008
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Therapeutic disease CTD_human CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer. 18086299 2007
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Biomarker disease CTD_human Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study. 17614302 2007
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Therapeutic disease CTD_human Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study. 17614302 2007
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Biomarker disease CTD_human CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer. 18086299 2007
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Therapeutic disease CTD_human Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial. 16596621 2006
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Biomarker disease CTD_human Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401. 16682728 2006
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Therapeutic disease CTD_human Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer. 16495393 2006
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Biomarker disease CTD_human Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial. 16596621 2006
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Biomarker disease CTD_human Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer. 16495393 2006
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Therapeutic disease CTD_human Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401. 16682728 2006
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Biomarker disease CTD_human Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer. 16446318 2006
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Biomarker disease CTD_human Investigating the combination of trastuzumab and HER2/neu peptide vaccines for the treatment of breast cancer. 16865596 2006
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Therapeutic disease CTD_human Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer. 16446318 2006
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Biomarker disease CTD_human Metastatic breast cancer: an updating. 16950593 2006
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Biomarker disease CTD_human Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer. 16978400 2006
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Therapeutic disease CTD_human Investigating the combination of trastuzumab and HER2/neu peptide vaccines for the treatment of breast cancer. 16865596 2006